Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2008
05/20/2008US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder
05/20/2008US7375129 Bis-indole pyrroles useful as antimicrobials agents
05/20/2008US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators
05/20/2008US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/20/2008US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine]
05/20/2008US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide
05/20/2008US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis
05/20/2008US7375099 Malonamide derivatives
05/20/2008CA2432223C Pyrazole compounds useful as protein kinase inhibitors
05/20/2008CA2415681C Pyrrolidine derivatives
05/20/2008CA2395717C Fused imidazolium derivatives
05/20/2008CA2350801C Hiv replication inhibiting pyrimidines
05/20/2008CA2298461C Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
05/20/2008CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants
05/15/2008WO2008058198A1 Methods of making compounds having a beta-adrenergic inhibitor and a linker and methods of making compounds having a beta-adrenergic inhibitor, a linker and a phosphodiesterase inhibitor
05/15/2008WO2008058037A1 Compounds and compositions as protein kinase inhibitors
05/15/2008WO2008057940A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
05/15/2008WO2008057857A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
05/15/2008WO2008057856A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
05/15/2008WO2008057601A2 Organic compounds
05/15/2008WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008WO2008055950A1 Novel inhibitors of glutaminyl cyclase
05/15/2008WO2008055947A1 Novel inhibitors of glutaminyl cyclase
05/15/2008WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
05/15/2008WO2008055847A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
05/15/2008WO2008055808A1 Indole and benzofuran 2-carboxamide derivatives
05/15/2008WO2008037789A8 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
05/15/2008WO2008036843A3 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
05/15/2008WO2007018941A3 Pyrimidyl-thiophene derivatives
05/15/2008US20080114169 Intermediates of active esters for peptide synthesis, labeling, analysis; purity
05/15/2008US20080114158 Yellow anionic disazo dyes
05/15/2008US20080114052 Cyclic derivatives as modulators of chemokine receptor activity
05/15/2008US20080114051 Pyrrolidine derivatives as prostaglandin modulators
05/15/2008US20080114050 Use of 5-(2-Cyano-5-pyrolyl)-2-indolinones for contraception; e.g. 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile; also use in hormone replacement therapy, dysmenorrhea, premenstrual syndrome, hormone-dependent cancers, uterine bleeding
05/15/2008US20080114045 Process for the Production of Candesartan
05/15/2008US20080114030 Diarymethyl and related compounds
05/15/2008US20080114010 Novel Substituted Imidazole Compounds
05/15/2008US20080114008 Quinazoline Derivatives as Antiviral Agents
05/15/2008US20080113998 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
05/15/2008US20080113993 Barbituric acid analogs as therapeutic agents
05/15/2008US20080113980 Substituted-2-imidazoles
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008US20080113967 Enzyme modulators and treatments
05/15/2008US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use
05/15/2008US20080113944 Novel Indole Derivatives
05/15/2008US20080110536 for automotive restraint systems; 2,3-Bis (tetrazolo-5-yl) nitrobenzene and 3,4-Bis (tetrazolo-5-yl) nitrobenzene claimed: reduced solids; one step reaction of 2,3-dicyano Nitrobenzene, Sodium azide and Zinc Bromide
05/15/2008CA2668959A1 Indole and benzofuran 2-carboxamide derivatives
05/15/2008CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators
05/15/2008CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008CA2668429A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
05/15/2008CA2668190A1 Compounds and compositions as protein kinase inhibitors
05/15/2008CA2667710A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
05/14/2008EP1919908A1 Triazole derivatives as modulators of dopamine d3 receptors
05/14/2008EP1919901A1 Substituted piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919900A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
05/14/2008EP1919899A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919898A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919890A1 Pyrazolone derivatives for the treatment of tuberculosis
05/14/2008EP1919881A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders
05/14/2008EP1919878A1 Pyridazinone derivatives as thyroid hormone receptor agonists
05/14/2008EP1919869A1 Novel indole compounds
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/14/2008CN101180292A 2-azetidinyl-4-(lH-pyrazol-3-ylamino)pyrimidines as inhibitors of insulin-like growth factor-i receptor activity
05/14/2008CN101180278A 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators
05/14/2008CN101180273A Methods of synthesizing 6-alkylaminoquinoline derivatives
05/14/2008CN100387595C New triazole organic compounds comprising benzotriazole, and its preparing method and use
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371870 Benzimidazolone compound
05/13/2008US7371772 Bicyclic compound, production and use thereof
05/13/2008US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
05/13/2008US7371764 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide
05/13/2008US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/13/2008US7371759 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents
05/13/2008US7371755 Antiviral agents
05/13/2008US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
05/13/2008US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/08/2008WO2008055233A1 Protein kinase inhibitors
05/08/2008WO2008054538A2 Lead-free primary explosives
05/08/2008WO2008054531A2 Gas generant compositions
05/08/2008WO2008054530A2 Gas generant compositions
05/08/2008WO2008054529A2 Gas generant compositions
05/08/2008WO2008054528A2 Gas generant compositions
05/08/2008WO2008054398A2 Photochemical methods and photoactive compounds for modifying surfaces
05/08/2008WO2008053319A1 Amide resorcinol compounds
05/08/2008WO2008053221A2 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates
05/08/2008WO2008052934A1 Novel substituted pyrimidines as cysteine protease inhibitors
05/08/2008WO2008052907A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008052352A1 Substituted quinone indoleamine 2,3-dioxygenase (ido) inhibitors and syntheses and uses therefor
05/08/2008WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
05/08/2008WO2008034891A3 Novel genes related to glutaminyl cyclase
05/08/2008WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
05/08/2008WO2008009963A3 Pyrimidine derivatives as modulators of parathyroid hormone receptors
05/08/2008US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation
05/08/2008US20080108814 For treatment of various forms of neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease
05/08/2008US20080108811 Aromatic Amine Derivative and Organic Electroluminescent Device Using Same
05/08/2008US20080108810 Prepared by reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting product with an alkali metal salt of a malonate diester to replace 4-fluoro group with malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation; use in treatment of HIV
05/08/2008US20080108808 Dipeptidyl peptidase inhibitors
05/08/2008US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
05/08/2008US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc